SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Trading Statement

13 Dec 2007 07:01

Rentokil Initial PLC13 December 2007 13 December 2007 RENTOKIL INITIAL PLC (RTO) TRADING UPDATE In our third quarter trading update for the period to 30 September 2007 we saidthat while business to business trading in City Link, our express parcelsdelivery business, had shown good year-on-year growth, the business to consumer(B to C) segment had softened over the quarter. This was a continuation of whatwe believe to be an industry wide trend. Operational performance within City Link is strong with service levels higherthan this time last year. Customer retention levels remain good and we continueto win new business. However, during the fourth quarter, the anticipated surgein volumes seen in prior years in the B to C segment in the run up to Christmashas been later and less than expected. B to C volumes have slipped below thelevel experienced this time last year, and business to business volumes, whichhad been significantly ahead, are now in line with last year's levels. As aresult fourth quarter profits from City Link are likely to be up to ยฃ10 millionbelow our expectations. This will have a similar impact on the results for thegroup as a whole. As we said at the time of our third quarter update on 8 November we believe thatthis slowdown in B to C volumes is a direct result of weaker consumer spendingin a challenging retail environment. Progress on the integration of TargetExpress continues to deliver synergy benefits ahead of original plan and in linewith the Q3 statement. The physical integration of depots will commence inJanuary 2008. Trading in our other divisions remains in line with our expectations. Rentokil Initial plc's Preliminary results for the 12 months to 31 December 2007will be announced on Tuesday, 26 February 2008. Enquiries: Shareholder/analyst enquiries:Andrew Macfarlane, Chief Financial OfficerKatharine Rycroft, Head of Investor Relations Rentokil Initial plc 020 7592 2700 Media enquiries:Malcolm Padley, Head of Corporate Communications Rentokil Initial plc 07788 978199Kate Holgate / Tom Williams Brunswick Group 020 7404 5959 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.